Patent · US Expired

Immunotherapeutic aryl amides

US6284780A · kind A · utility

7Cited by
11References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 9, 2000
Grant dateSep 4, 2001
Priority date—
Expiry dateFeb 9, 2020

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel aryl amides are inhibitors of tumor necrosis factor .alpha. and can be used to combat cachexia, endotoxic shock, and retrovirus replication. A typical embodiment is N-benzoyl-3-amino-3-(3',4'-dimethoxyphenyl)propanamide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.